Nextremity Solutions recalls Nextra Cannulated Hammertoe Standard Instrument Kit-indicated for small bone reconstruction limited to inter-digital re…
- Recall date
- January 13, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0740-2022
- FDA classification
- Class II
- Brand / firm
- Nextremity Solutions
- Sold / distributed
- US Nationwide distribution in the states of AZ, IL, GA, LA, MD, NY, PA, TX, WA.
Why it was recalled
During insertion of the middle phalanx implant into bone, the driver may deform the implant locking mechanism and result in inadequate mating force between the middle and proximal phalanx implants, resulting in surgical delay, in-situ removal of the implant, use of alternative surgical approach, disassembly of the implants post-operatively, and revision
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nextra Cannulated Hammertoe Standard Instrument Kit-indicated for small bone reconstruction limited to inter-digital repair and fusion of the lesser toe SKU: CH-STD-KT
Get recall alerts
Free email alert whenever Nextremity Solutions has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Nextremity Solutions